Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy

• Status: Completed
• Trial end date: 2011-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This randomized control study is aimed to determine efficacy of umbilical cord blood and erythropoietin combination therapy for children with cerebral palsy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sung Kwang Medical Foundation
• Treatments: Epoetin Alfa

Criteria

Inclusion Criteria:

• Known cerebral palsy

• Willing to comply with all study procedure

Exclusion Criteria:

• High risk of pneumonia or renal function deterioration after using of immunosuppressant

• Presence of known genetic disease

• Possibility of drug hypersensitivity which is related to this study remedy

• History of previous cell therapy

• Poor cooperation of guardian,including inactive attitude for rehabilitation

• Intractable seizure disorder

• Autism